prompted Docuprene Tablets Generic Name: docusate sodium Dosage Form: tablet Overview Side Effects Dosage Professional Interactions More Pregnancy Warnings Breastfeeding Warnings User Reviews Support Group Q & A Pricing & Coupons Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. DOCUPRENE Active Ingredient (in each tablet) Purpose Sodium Dioctyl Sulfosuccinate 100mg Stool Softner Each tablet contains 8 mg. of Sodium Inactive Ingredients Croscamellose Sodium, Dicalcium Phosphate, Magnesium Silicate, Magnesium Stearatem Microcrystalline Cellulose, Pharmceutical Glaze, Silica, Sodium Benzoate and Stearic Acid. Uses: For the prevention of dry hard stools For relief of occasional constipation This product generally produces bowel movement with 12 to 72 hours. Warnings Do not use laxative products for longer that one week unless directed to do so by a doctor and if you are presently taking mineral oil, unless told to do so by a doctor. Ask a doctor before use if you have: Abdominal pain, nausea, vomiting, noticed a sudden change in or you fail to have a bowel movement after use. These could be signs of a serious condition. If pregnant or breast-feeding , ask a doctor before use. Other Information Store at room temperature 68- 77 degrees F For Questions or Comments Please email: info pnarx.com or Call: 877-329-2592 Keep out of reach of children In case of overdose, get medical help or contact a Poison Control Center right away. Adults and children 12 years of age and older: Take 1 or 2 tablets daily Children Under 12 years of age: Do not use, Consult a doctor before use. NDC 45861-0201-60 DOCUPRENE 100 mg Sodium Dioctyl Sulfosuccinate 60 Tablets Made in USA Patent Pending Manufactured For Pharmaceutica America Glendale CA DOCUPRENE docusate sodium tablet Product Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:45861-201 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength DOCUSATE SODIUM (DOCUSATE) DOCUSATE SODIUM 8 Product Characteristics Color white (White) Score no score Shape ROUND Size 11mm Flavor Imprint Code CPC513 Contains Packaging # Item Code Package Description 1 NDC:45861-201-60 60 TABLET (TABLET) in 1 BOTTLE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part334 06/16/2010 Labeler - Pharmaceutica North America, Inc. (962739699) Establishment Name Address ID/FEI Operations Contract Pharmacal Corporation 057795122 manufacture Revised: 06/2010 Pharmaceutica North America, Inc. Next Interactions Print this page Add to My Med List More about Docuprene (docusate) Side Effects During Pregnancy or Breastfeeding Dosage Information Drug Interactions Support Group Pricing & Coupons En Español 0 Reviews Add your own review/rating Drug class: laxatives Consumer resources Docuprene oral/rectal Professional resources Docusate Sodium (FDA) Other brands: Doc-Q-Lace Related treatment guides Constipation FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Drug Status Rx OTC Availability Rx and/or OTC N Pregnancy Category Not classified N/A CSA Schedule Not a controlled drug Drug Class Laxatives Related Drugs laxatives MiraLax , Colace , docusate , polyethylene glycol 3350 , senna , Metamucil Constipation MiraLax , Colace , docusate , polyethylene glycol 3350 , magnesium oxide , senna , Amitiza , Metamucil , Linzess , bisacodyl , Dulcolax , psyllium , Senokot , linaclotide , FiberCon , Citrucel , GlycoLax , Dulcolax Stool Softener , Doc-Q-Lace , lubiprostone , Milk of Magnesia , methylcellulose , More... Docuprene Rating No Reviews - Be the first! No Reviews - Be the first! Not Rated - Be the first! fee
of issues of safety Docuprene Tablets ordinary
EmoticonEmoticon